The gamecock. (Columbia, S.C.) 1908-2006, March 07, 2001, Page 4, Image 4
School shooting kills
two, injures several
by Ben Fox
Associated Press
SANTEE, Calif. — The “angry young
man” accused of killing two fellow students
had fired randomly and still had eight bullets
in his gun when police cornered him in a .
school bathroom, investigators said Tuesday.
Friends said the scrawny 15-year-old
freshman accused in the nation’s latest high
school bloodbath talked about his plans over
the weekend, and they took him seriously
enough to pat him down before classes started
Monday.
One adult even warned Charles Andrew
“Andy” Williams not to commit ^‘a
Columbine,” and tried to call the boy’s fether
but didn’t follow through. But no one is
known to have reported the threats that
preceded Monday’s attack that also wounded
13 at Santana High School.
During a news conference, authorities
said the carnage could have been much worse
if not for the swift actions-of a sheriff’s deputy
and an off-duty police officer who was on
campus to register his child in the school.
When Williams surrendered, his .22
caliber revolver was fully loaded with eight
• rounds, its hammer cocked, investigators
said. He came to school with as many as
40 rounds, investigators said.
“I do believe that if it had not been for
the conduct of the people involved... it
would have been even worse,” Sheriff Bill
Kolender said.
The boy fired indiscriminately, sheriff’s
I
Lt. Jerry Lewis said. Most of the hit
students were struck as they fled down
a hallway between the school’s library
and administration office.
“The information we have from
the evidence and the witnesses (is) the
suspect was firing randomly at anybody
who was going by,” Lewis said “Any
student who was going by, he was
shooting at.”
Authorities said the boy was
cooperating in interviews, but they
couldn’t shed further light on his
possible motives.
“(Witnesses) all said he was mad
“' i
at something. We don’t know if he
was mad at the school, mad at
students, made at life, mad at home,”
Lewis said. “He was an angry young
man.”
Although school was closed
Tuesday, students, parents and others
gathered outside to grieve and place
flowers at a makeshift memorial site.
The school is to reopen Wednesday
to give students a chance to talk about
Monday’s shooting.
College Press Exchange
Brian Kays prays in front of Santana High School in Santee,
Calif., the scene of a shooting rampage earlier in the day.
2000 census count
officially accepted
■ Announcements comes despite estimates
of 3.3 million mostly minority undercounts
by Genaro Armas
Associated Press
WASHINGTON —The Bush
administration declared the actual “head
count” from the 2000 census to be the
official population numbers for
congressional redistricting, despite
estimates snowing
3.3 million people,
mostly minorities,
were missed.
Commerce
Secretary Don
Evans agreed
Tuesday with a
census Bureau recommenaauon mai me
initial, raw count provided the most nearly
accurate snapshot of America. Democrats
and civil rights groups had called for the
use of a second, separate population tally
statistically adjusted to protect against
the undercount.
But supporters of adjustment had
expected Evans’ decision following the
bureau’s recommendation this past week.
It might quiet — but not end — a long
political dispute between Democrats and
Republicans over whether, and how, to
count missed Americans.
Evans called the initial figures the
most accurate census in the history of
the nation.
The first numbers, for New Jersey
and Virginia, are expected to be
released Wednesday, and all states
must have their redistricting data by
April 1.
The numbers will be used by state
lawmakers to redraw congressional
aismci oounaanes 10
reflect population
shifts, as is required
every 10 years.
States will be
able to use the figures
to remap state and
local legislative
district boundaries as well. Also, the
numbers could be used to redistribute
more than $185 billion in federal
Census seepages
‘We have achieved
i quality count.’
Don Evans
Commerce Secretary
News Briefs
_
■ Navy admiral
gives testimony
on sub collision
PEARL HARBOR, Hawaii (AP)
— A series of missteps by the crew of
the USS Greeneville paved a destructive
path that led to the submarine’s fatal
collision with a Japanese fishing boat,
according to testimony from a Navy
admiral.
The mistakes varied from the
submarine rushing to get back on schedule
to vital sonar data not getting to the
skipper, Rear Adm. Charles Griffiths
testified Monday, the opening day of a at
Navy court of inquiry into the Feb. 9
collision.
Griffiths, who conducted the
preliminary investigation, described a
submarine crew so consumed with putting
on a good show for 16 civilian guests that
standard procedures fell by the wayside.
The nuclear-attack submarine was
demonstrating an emergency surfacing
drill for the guests when it smashed into
the Ehime Maru fishing boat.
J TIGHT?
1 EARN CASH AND SAVE 1
1 LIVES DONATING PLASMA M
j§f New donors can earn W
TIL $65 this week! ||
% Help Sera-Tec help others hy M
M donating life saving plasma. ||
MUST BE AT LEAST 18 YRS. OLD,
AT LEAST HO LBS., AND HEALTHY /fed
BRING PICTURE ID AND SOCIAL SECURITY CARI
—
Ready to slime someone with a little—
Deltaiataj
1st Amri Trtk Tq
.....
■ March 24th @ 2 till you lose on ■
! Field F "
Tug of War in Green JELL-0
■ 8 people + $40 = 1 TEAM ■
" Contact Jill 544-0906 or Amanda at ■
■ 544-2265 for more info ■
b ALL $ goes to Brennen Elementary
■■■■■■■■■■■■■■■■■■■■■■■■
LUNELLE™ Monthly Contraceptive Injection
medroxyprogesterone acetate and estradiol
cypionate injectable suspension
LUNELLE” Monthly Contraceptive Injection
(Itfce all hormonal contraceptives) is
intended to prevent pregnancy.
It does not protect against HIV infection
(AIDS) and other sexually transmitted
This summaiy contains important information
about LUNELLE™ Monthly Contraceptive
Injection. It is not mean to lake the place of dis
cussions with your doctor and it cannot replace
your doclorb advice. Only your doctor can assess
the benefits and risks to decide If LUNELLE”
Monthly Contraceptive Injection is right lor you.
Talk to your doctor oi pharmacist, or other pre
scribing healthcare professional, if you do not
understand any of this information oc if you want
to know more about LUNELLE™ Monthly
Contraceptive Injection.
CEPTTvl INJECTION7 M0NTHLV C0NTRA
LUNELLE™ Monthly Contraceptive Injection is a
type ol homtonal birth control Dial is giwn as an
injection (a shot) in your arm. thigh, or buttock
once a month to prevent pregnancy, k contains
hormones which have elfccts similar to the nafura
hormones, estrogen and progesterone, produced
in your body. Similar combinations ol hormones
are found in some oral contraceptives also known
as 'birth control pills' or the pill.' When you
receive your injections ones a month as pre
scribed, LUNELLE™ Monthly Contraceptive
Injection is as effective as birth control pills. Wher
given according to the prescribed schedule,
LUNELLE™ Monthly Contraceptive Injection is
effective in preventing pregnancy during Ihe cycle
tn which it is given Clinical studies have shown
that when women receive LUNELLE™ Monthly
Contraceptive Injection according to Ihe recom
mended schedule, the failure rale of this method
ol birth control s less than 1% per year.
Cigarette smoking increases me risk m
serious cardiovascular side effects from
hormonal contraceptive use. This risk
increases with age and with heavy smok
ing (15 or more cigarettes per day) and Is
quite marked in women over 35 years of
age. Women who use hormonal contra
ceptives are strongly advised not to smoke
Some women should nd use hormonal contra
ceptives. For example, you should not lake
LUNELLE" Monthly Contraceptive Injection if yd
are pregnant or think you may tie pregnant. You
should also nd use LUNELLE" Monthly
Contraceptive Injection if you have any of the lot
lowing concfidons:
• A history of heart attack or stroke
• Blood dots in the legs (thromtxjphlepitis).
lungs (pulmonary embolism), or eyes
• A history d blood dots in the deep veins d
your tegs
• Chest pain (angina pectoris)
• Known or suspeded breast cancer or cancer ol
the lining of the uterus, cervix or vagina
• Unexplained vaginal bleeding (until a diag
nosis is reached by your dodor)
• Yellowing ol Die whiles of Die eyes or ol the
skin (jaundice) during pregnancy or during
previous use of the pill or other hormonal
contraceptives
• Liver tumor (benign or cancerous)
• Known or suspected pregnancy
• Allergy to any d the ingredients contained
LUNELLE" Monthly Contraceptive Injection
• Over age 35 and smoke 15 or more cigarettes
per day
Tell your healtti care provider it you have ever had
any of these conditions. Your health care provider
can recommend a safer method ot birth control.
ME THERE OTHER THINGS IQ. CQfL
S1PER BEFORE TAKING LUNELLE"
MONTHLY CONTRACEPTIVE INJECTION?
For the majority ot women, hormonal contracep
tives can be taken safely. But there are some
women who are at high risk ot developing certain
senous diseases that can be life-threatening or
may cause temporary or permanent disability. Tell
your health care provider it you have:
• Breast nodules, fibrocystic disease ot the
breast an abnormal breast x-ray or mammo
gram, strong family history of breast cancer
• Diabetes
• Elevated cholesterol or triglycerides
• High blood pressure
• Migraine or other headaches or epilepsy
• Mental depression
• Gallbladder, heart ot kidney disease
• History of scanty or irregular menstrual periods
• Smoke, especially if 35 years or older
Women with any ot these conditions should be
checked often by their health care provider it they
choose to use LUNELLE™ Monthly Contraceptive
•Injection.
Also, be sure to inform your dodot or health care
provider it you smoke ot ate on any medications.
Yt^AKJ«BBIBffnClffF8WrTH
1. Risk of developing blood clots, heart
attacks, and strokes
muou uue d!VJ urucwye ui uiuuu vu&ueis eue u c
most serious side effects of taking hormonal con
traceptives. In particular, blood clots can occur in
the legs and can travel to the lungs and can cause
sudden blocking of the vessel carrying blood to
the lungs. Rarely, clots occur in the blood vessels
ol the eye and may cause blindness, double
vision, or impaired vision.
If you lake hormonal contraceptives such as
LUt€LLP Monthly Contraceptive Injection and
need elective surgery, need to stay in bed for a
prolongs) illness, or have recently had a baby,
you may be at risk of developing blood clots You
should consult your doctor about stopping hor
monal contraceptives three to lour weeks before
surgery and not taking hormonal contraceptives
for two weeks alter surgery or during bed rest You
should also not take hormonal contraceptives
soon after delivery of a baby. It is advisable to wait
for at least tour weeks after delivery before using
hormonal contraceptives such as LUNELLE™
Monthly Contraceptive injection. (See also the
section on Breast Feeding in WHAT PRECAU
TIONS SHOULD BE FOLLOWED DURING THE
USE OF LUNELLE MONTHLY CONTRACEPTIVE
INJECTION?)
Hormonal contraceotives may also increase the
tendency to develop strokes (stoppage or capture
of blood vessels in me brain) and angina pectoris
and heart attacks (blockage of blood vessels in the
heart). Any of these conditions can cause death or
disability.
Smoking greatly increases the possibility of devel
oping blood clots or suffering heart attacks and
strokes. Furthermore, smoking and the use of hor
monal contraceptives greatly increase the chances
of developing and dying of head disease, particu
larly if you are over 35 years of age.
2. Gallbladder disease
Hormonal contraceptive users probably have a
greater risk than non-users of having gallbladder
disease.
3. Liver tumors
In rare cases, hormonal contraceptives can cause
benign but dangerous liver tumors Thesebenign
liver tumors can rupture and cause fatal internal
bleeding. In addition, a possible txjt not definite
association has been lound with hormonal contra
ceptives and liver canters in two studies, in which
a lew women who developed these very rare can
cers were found to have used hormonal contra
ceptives lor long periods. However, liver cancers
are extremely rare. The chance of devetojing liver
cancer Irom using hormonal contraceptives is thus
even rarer.
4. Cancer of the reproductive organs and
breasts
There is, at present, no confinned evidence that
oral hormonal contraceptives increase tie risk ot
cancer ol tie reproductive organs in human stud
ies Studies to date ot women taking the pill have
repotted conflicting findings on whether pill use
increases the risk ot developing cancer of the
breast. Most of the studies on breast cancer and
pill use have lound no overall increase in tie risk
ot developing breast cancer, although some stud
ies have reported an increased risk ol developing
breast cancer in certain groups ot women.
Some studies have lound an increase in the inci
dence of cancer ot the cervix in women who use
oral hormonal contraceptives. However, this find
ing may be related to factors other than the use ot
oral hormonal contraceptives.
Studies have lound that women who used
injectable hormonal contraceptives (Depo-Provera
Contraceptive Injection) had no increased overall
risk ol developing cancer ol the breast, ovaty.
uterus, ot cervix. However, women under 35 years
ot age whose first exposure to Depo-Provera
Contraceptive Injection was within the previous 4
to 5 years may have a slightly increased risk ot
developing breast cancer similar to that seen with
oral contraceptives.
Women who use hormonal contraceptives and
have a strong tarnily history ol breast cancer or
who have breast nodules or abnormal mammo
gram should be closely lolloved by their dodors.
5. Changes in hone mineral density
Use ol injectable hormonal contraceptives con
taining the progesterone-type hormone lound in
LUNELLE" Monthly Contraceptive Injection may
be associated with a decrease in the amount ol
mineral stored in your bones. This could increase
your risk ot developing bone fractures The rale ol
bone mineral loss is grealest in the early years of
use ol this type ol contraceptive, but alter that, il
begins to resemble the normal rate ol age-related
bone mineral loss.
b. Anergic reactions
Severe allergic reactions have been reported in
some women using injectable hormonal contra
ceptives containing the progesterone-type hor
mone found in LUNELLE™ Monthly Contraceptive
Injection. Allergic reactions occurring in women
using LUNELLE™ Monthly Contraceptive Injection
have been mainly skin reactions, and not respira
tory in narure. Serious allergic reactions require
emergency medical treatment.
ESTIMATED RISK OF DEATH FROM A BIRTH
CfflfJRQl METHOD OR PREGNANCY
All methods ot birth control and pregnancy are
associated with a risk ot developing certain dis
eases trial may lead to disability or death An esti
mate ol the number ol deaths associated with dil
lerent methods ot birth control and pregnancy has
been calculated
The risk ot death Irom any birth control method is
less than the risk ot childbirth, except lot oral hor
monal contraceptive users over the age ot 35 who
smoke and oral hormonal contraceptive users
over the age ot 40 even if they do not smoke For
women aged 15 to 39, the risk ol death was high
est with pregnancy (7-26 aaths per 100,000
women, depending on agti. Among oral hormon
al contraceptive users who do not smoke, the risk
ot death is always lower than that associated with
pregnancy lor any age group, although over the
age ol 40. the risk increases to 32 deaths per
100,000 women, compared to 28 associated with
pregnancy at that age. However, for oral hormonal
contraceptive users who smoke and are owr the
age ot 35, the estimated number or deaths
exceeds those for other methods ol birth control.
It a woman is over the age ol 40 and smokes,
her estimated risk ol death is lour times higher
(117/100,000 women) than the estimated risk
associated with pregnancy (28/100,000 women)
in that age group.
An Advisory Committee ol the FDA discussed this
issue in 1989 and recommended that Ihe benefits
ot oral contraceptive use by healthy, non-smoking
women over 40 years ol age may outweigh the
possible nsks. However, women ol all ages are
cautioned to use the lowest dose oral contracep
tive that is effective, and are strongly advised not
to smoke
Call your doctor immediately if any ot these
adverse effects occur while you are taking
LUNELLE" Monthly Contraceptive Injection.
• Sharp chest pain, coughing ot blood, or sudden
shortness ol breath (indicating a possible clot
in the lung)
• Rain in the call (mdicaljng a pcesibie dot in the leg)
• Crushing chest pain or heaviness in the chest
(indicating a possible heart attack)
• Sudden severe headache or vomiting, dizziness
or tainting, disturbances ot vision or speech,
weakness, or numbness in an arm ot leg
(indicating a possible stroke)
• Sudden partial or complete loss ol vision
(indicating a possible clot in Ihe eye)
• Breast lumps (indicating possible breast cancer
ot fibrocystic disease of the breast; ask your
doctor or health care provider to show you how
tn PYaminp v/nnr hrKrctc\
• Severe pain or tenderness in the abdominal
area (indicating a possibly ruptured liver tumor,
ovarian cyst or pregnancy outside the uterus)
• Difficulty in sleeping, weakness, lack ol energy,
fatigue, or change in mood (possibly indicating
severe depression)
• Jaundice or a yellowing ol the skin or eyeballs,
accompanied frequently by fever, fatigue, loss
ol appetite, dark-colored urine, or light-colored
bowel movemerts (indicating possible liver
problems)
• Persisdenl pain, pus. a bleeding at Hie injection site
• Unusually heavy vaginal bleeding
WHAT ARE THE POSSIBLE SIDE EFFECTS
DE LUNEllE™ MONTHIY CONTRACEP
TIVE INJECTION’
1. Vaginal bleeding
Most women using LUNELLE1" Monthly
Conlraceptive Injection experience alteration ol
menstrual bleeding. Bleeding patterns may vary
from a single monthly bleed lo no bleeding at all
or slight staining between menstrual periods to
Irequenl, prolonged, and/or unpredictable bleed
ing. In any given injection interval, approximately
50% of women using LUNELLE" Monthly
Contraceptive Injection experience withdrawal
bleeding that begins 20-25 days alter tie injec
tion. Withdrawal bleeding lasts more than 7 days
in 42% ol women during tie first month ol use
and in 29% ol women at the end ol one year ol
use. In any given injection interval, approximately
15% of women may have no bleeding al all and
10% may experience bleeding or spoiling at vari
ous times in tie cycle. Irregular bleeding oten
occurs during the first few months ol LUNELLE"
Monthly Contraceptive Injection use and may per
sist with continued use in up lo one third ol
women. Your menstrual blood flow may be heav
er ot lighter, and there may be no bleeding, fewer
lays ol bleeding, or more days ot bleeding than
what you have previously experienced. Such
aleeding usually does not indicate any serious
aroblems. It an altered bleeding pattern persistsor
he bleeding is severe, discuss it with your health
are provider. There is also a small risk that
[painful) cramps may be associated with bleeding
2. Weight change
Weight gain is a common side effect in women
jsing LUNELLE” Monthly Contraceptive
Injedion. The average expected weight gain is 4
pounds in the first year ot use Some women gain
more than 10 to 20 pounds in the first year.
Women have gained as much as 49 pounds or
lost as much as 48 pounds in one year ol use.
Clinical trials showed wide variability in individual
weight change with an increasing percentage ol
LUNELLE” Monthly Contraceptive Injedion users
axpetiencing weight change in excess ot 10 and
20 pounds with continued treatment.
3. Contact lenses
If you wear contact lenses and notice a change in
vision or an inability to wear your lenses, contact
your doctor or health care provider.
4. Fluid retention
Hormonal contraceptives may cause edema (fluid
retention) with swelling of the fingers or ankles and
may raise your blood pressure, fi you experience
fluid retention, contact your dodor ot health care
provider.
5. Other side effects
Other side effects may include br^st pain or ten
derness. acne, change in appetite, nausea, headache,
nervousness, depression, mood changes, changes
in sexual desite, dizziness, loss ol scalp hair, rash,
and vaginal infections. It any ot these side effects
bother you, call your health care provider.
WHAT PRECAUTIONS SHOULD BE
FOLLOWED DURING USE OF LUNELLE"
MONTHLY CONTRACEPTIVE INJECTION?
traceptives before or during early pregnancy
You may not menstruate regularly after you
receive an injection of LUNELLE™ Monthly
Contraceptive Injection. If you have received your
injections regularly and miss one menstrual peri
od, be sure to inform your health care provider.
The risk of unexpected pregnancy for women
receiving injectable contraceptives as scheduled is
very low. If you have not received your injections
as scheduled and missed a menstrual period, or if
you missed two consecutive menstrual periods,
you may be pregnant. Check with your health care
provider immediately to determine whether you
are pregnant. Do not continue the injections until
you are sure you are not pregnant, but use another
method of ccniraception.
There is no conclusive evidence that oral hormonal
contraceptive use is associated with an increase in
birth defects, when taken inadvertently during early
pregnancy Nevertheless, hormonal contraceptives
should not be used during pregnancy.
With Depo-Provera Contraceptive Injection, there
have been reports of an increased risk of low birth
weight and neonatal infant death or other health
problems in infants conceived close to the time of
injection. However, these pregnancies are uncom
mon. Children exposed in the womb to one of the
hormones found in LUNELLE™ Monthly
Contraceptive Injection (MPA), and followed to
adolescence, shovied no evidence of any adverse
effects on their health including their physical,
mental, sexual or social development.
If you think you may have become pregnant while
using LUNELLE™ Monthly Contraceptive Injection,
see your health care provider as soon as possible.
You should check with your health care provider
aboE risks to your unborn child from any medica
tion taken during pregnancy.
2. While breast feeding
If you are breast feeding, consult your health
care provider before starting hormonal contracep
tives. including LUNELLE" Monthly
Contraceptive Injection, Some ol the drugs in hor
monal contraceptives are passed on to the child in
breast milk. A lew adverse effects on the child
have been reported, including yellowing ol It*
skin (jaundice) and breast enlargement. In addi
tion. hormonal contraceptives may decrease the
amount and quality of your milk. To insore the
best quantity and quality of your breast milk, you
should wait until 6 weeks after chikjbirth before
you start using LUNELLE" Monthly Contraceptive
Injection. II possible, do not use hormonal contra
ceptives while breast feeding.
Breast feeding provides only partial protection
born becoming pregnant and Ibis partial protec
tion decreases significantly as yoo breast leed lor
longer periods ol time. You should use another
method of conbaception while breast feeding and
consider starting hormonal contraceptives only
alter you have weaned your child completely.
3. Laboratory tests
It you are scheduled lot any laboratory tests, tell
your doctor you are taking a hormonal contracep
tive Certain btood tests may be affected by hor
monal contraceptives
4. Drag interactions
Certain drugs may interact with hormonal contra
ceptives lo make them less effective in preventing
pregnancy or cause a change in bleeding patterns.
Such drugs include aminoglutethimide, rifampin,
drugs used lor epilepsy such as barbiturates (tor
example, phenobarbital). carbamazepine, and
phenytoin (Dilantin is one brand ol this drug),
phenylbutazone (Butazolidin is one brand), herbal
products containing SI. Johns Wort (hypencum
perforatum), and possibly certain antibiotics. You
may need to use an additional contraception
method when you take drugs which can make
hotmonal contraceptives less effective Drug inter
nntinn nh irfioc Kntm rvrvf hnon onnWi intorf noth
LUNELLP Monthly Contraceptive Injection.
5. Sexually transmitted diseases
This product (like all hormonal contracep
tives) is intended to prevent pregnancy.
It does not protect against transmission of
HIV (AIDS) and other sexually transmitted
diseases such as chlamydia, genital her
pes, genital warts, gonorrhea, hepatitis B,
and syphilis.
6. Weight change
LUNELLP Monthly Contraceptive Injection may
cause weight gain of more than 10 pounds
WHEN DQI GET MY LUNELIE™?MQNIH:
LUNELLP Monthly Contraceptive Injection can
only be effective if you receive your injections at
tie proper times.
First Injection
• Within the first 5 days of the start of your
normal menstrual period.
• If you are presently using another type of birth
control, your health care provider will decide
the best time for you to start LUNELLP
Monthly Contraceptive Injection. This will help
make sure you have continued contraceptive
coverage
• If you have recently been pregnant or had a
baby, discuss with your health care provider the
best time for you to start LUNELLP Monthly
Contraceptive Injection.
Next Injections
• LUNELLP Monthly Contraceptive Injection
must be given monthly, every 28 to 30 days and
no later than 33 days alter your last injection.
The time for your next injection is determined
by the number of days since your previous
injection, and not by the timing or amount of
your menstrual bleeding.
Even il you do not have any menstrual bleed
ing, you should still return once a month tor
your injection ol LUNELLE" Monthly
Contraceptive Injection.
• It is important that you receive eacti of your next
injections at the right time. It you cannot receive
your injection on time, contact your health care
provider to receive an earlier iniection.
What Happens it I Miss an Injection or Wait
Longer than 33 Days Between Injections?
• You coukl become pregnant il you miss your
Injection or wait longer than 33 days between
injections. The more days you wait, the greater
the risk that you could become pregnant
• Ask your health care provider to recommend
another type ol birth control (such as condoms
or a spermicide) lor you to use.
• Talk with your health care provider to find out
when you should receive your next injection ot
LUNELLE" Monthly Contraceptive Injection.
• Your health care provider may do a lest to make
sure you are not pregnant before giving you
your next injection ol LUNELLE" Monthly
Contraceptive Injection.
Pregnancy Due to Failure with LUNELLE™
Monthly Contraceptive Injection
The incidence ol failure with LUNELLE" Monthly
Contraceptive Injection resulting in pregnancy is
less than 1 percent (i.e., one pregnancy per 100
women pen year) it given every month as directed.
N you think that you may be pregnant, be sure to
call your health care provider.
What If I Want to Become Pregnant?
You will need to stop your monthly injections of
LUNELLE" Morthly Contraceptive Injection Most
women begin to produce eggs again (and could
become pregnant) atxxrt two to three months after
their last injection.
There may be some delay in becoming pregnant
alter you stop using hormonal contraceptives, inclu
ding LUNELLE” Monthly Contraceptive Injection.
coyAA/ianj' ii juu rrau mcyuiar 11 nx wti uai uyuiw
before you started using hormonal contraceptives.
There does not appear to be any increase in birth'
delects in newborn babies when pregnancy occurs
soon alter stopping hormonal contraceptives
WHAT SHOULD I KNOW ABOUTA
POSSIBLE OVERDOSE Of LUNELLE™
(MONTHLY CONTRACEPTIVE INJECTION)?
Serious ill effects have not been reportad todowing
ingestion ol lage doses o( oral Immoral cortocephes
by ycuig chMm Overdosaga may case reuses and
wihdmal bleeding in tales. In case cl ovettteage
coned you beam care provider Of pharmacist
Keep this and all dregs out of the reach of children.
OTHER INFORMATION
Your health care provider will take a medical
and family history before prescribing hormonal
contraceptives You should receive yearly physical
examinations by your health cate provider. Be sure
to inform your health care provider if there is a
family histoty oi any of the conditions listed previ
ously in mis leaflet. Be sure to keep all appoint
ments with your health care provider, because mis
is a time to determine if there are earfy signs of
side effects of hormonal contraceptive use. II you
want mote information about hormonal contracep
tives, ask your health care provider or pharmacist
lor a mote technical leaflet called the Prescribing
Information that you may wish to read.
Rx only
Manufactured by:
Pharmacia & Upjohn Company
Kalamazoo, Ml 49001, USA
CB-2-S
l Lunelle'
kad monthly contraceptive mjeclion
metJrcjciprgesierse acetate & estradd cywnate npcube suspension
Your ad here.
ip
•
f
get connected to
* over 30,000 readers.
Advertise in
The Gamecock.
Call 777-5064 for
Bmore information.
W$&0amcock